Five ways to bust pharma ghostwriting in medical, science journals

Posted By

Categories

Tags

See William Heisel’s column that offers advice to journal editors and to journalists. He writes:

“Investigative journalists uncovered a series of scandals in recent years that have revealed the huge role that drug and device companies play in manipulating journal publications and continuing medical education programs through ghostwriting, speaking fees and other gun-for-hire arrangements.

Journal editors, though, have been slow to respond. No journal has stepped up to say, “We have investigated the extent of industry influence on the research in our journal and here is what we found.” Absent that, patients worldwide are left to wonder whether the drug they are being prescribed, the device being implanted in their body or the advice they are being given by their physician is based on strong science.”

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Dr. Lawrence Kindo

May 4, 2010 at 5:23 am

I believe this kind of practice is not new but has found new takers in the medical industry. The company get the prescription and authentication, the doctor or investigator gets the moolah. I hope that more detailed investigations are done prior to publication. I know that would prove to be an expensive affair. But, what other choice do we have?